-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
DMK PHARMACEUTICALS Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2013 to Q3 2023.
- DMK PHARMACEUTICALS Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was -$44.7K, a 160% decline year-over-year.
- DMK PHARMACEUTICALS Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was -$249K.
- DMK PHARMACEUTICALS Corp annual Share-based Payment Arrangement, Expense for 2022 was -$340K, a 117% decline from 2021.
- DMK PHARMACEUTICALS Corp annual Share-based Payment Arrangement, Expense for 2021 was $2.02M.
- DMK PHARMACEUTICALS Corp annual Share-based Payment Arrangement, Expense for 2012 was $36.8K, a 89.9% decline from 2011.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)